Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Jad M Abdelsattar, M.D, FACS

Breast Surgical Onc · University of Oxford

View

Dr. Lauren Kopicky

Breast Surgical Onc · Cleveland Clinic

View

Dr. Jennifer Plichta

Breast Surgical Onc · Duke University

View

Dr. Sarah Blair

Breast Surgical Onc · UCSD

View

Dr. Karen Goodwin

Breast Surgical Onc · UCSF

View

Dr. Christin Collins

Breast Surgical Onc · MetroHealth

View

Dr. Philip Schauer

Bariatric Surgery · PBRC

View

Dr. Todd Rosengart

Cardiac Surgery · BCM

View

Dr. Larry Kaiser

Thoracic Surgery · UPenn

View

Dr. Neri Cohen

Thoracic Surgery · XVIVO

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    LTDr. Lorraine Tafra

    Dr. Lorraine Tafra

    Surgery · Breast Surgical Oncology
    Johns Hopkins Hospital
    lorraine

    Research

    Simultaneous expression of epithelial and immune cell markers in circulating tumor cells identified in patients with stage 4 breast cancer

    2025

    Via Communications Medicine

    Research

    American Society of Breast Surgeons and Society of Breast Imaging 2025 Guidelines for the Management of Benign Breast Fibroepithelial Lesions

    2025

    Via JAMA Surgery

    Research

    Liquid Biopsy Profiling with Multiple Tests in Patients with Metastatic Breast Cancer

    2024

    Via Journal of Molecular Pathology

    Research

    OncotypeDX Testing Does Not Benefit Patients with Estrogen and Progesterone Receptor Positive Grade 1 Breast Cancers: A TAILORx Validated Study

    2023

    Via Hematology/Oncology and Stem Cell Therapy

    Research

    Can Axillary Ultrasound Identify Node Positive Patients Who can Avoid an Axillary Dissection After Neoadjuvant Chemotherapy?

    2023

    Via The Journal of Surgical Research

    Research

    Recurrence Score Testing Does not Appear to Benefit Patients With Grade 1, Progesterone Receptor-Positive Breast Cancers: An Opportunity to Eliminate Overtreatment and Decrease Testing Costs

    2022

    Via Hematology/Oncology and Stem Cell Therapy

    Research

    Outcomes of Margin Reexcision after Oncoplastic Breast Reduction

    2022

    Via Plastic and Reconstructive Surgery – Global Open

    Research

    The Impact of Genomic Profiling on Adjuvant Therapy Recommendation in Postmenopausal Women with ER-Positive, T1-2 Breast Cancer: Can Genomic Profiling Eliminate the Need for Sentinel Lymph Node Biopsy?

    2021

    Via Clinical Breast Cancer

    Research

    Is Sentinel Lymph Node Biopsy Reliable After Recent Oncoplastic Breast Reduction?

    2021

    Via The American Surgeon

    Research

    Ultrasound-Based Nomogram Identifies Breast Cancer Patients Unlikely to Harbor Axillary Metastasis: Towards Selective Omission of Sentinel Lymph Node Biopsy

    2020

    Via Annals of Surgical Oncology

    Research

    A Three-Dimensional Bioabsorbable Tissue Marker for Volume Replacement and Radiation Planning: A Multicenter Study of Surgical and Patient-Reported Outcomes for 818 Patients with Breast Cancer

    2020

    Via Annals of Surgical Oncology

    Research

    Combined pathologic-genomic algorithm for early-stage breast cancer improves cost-effective use of the 21-gene recurrence score assay

    2018

    Via Annals of Oncology

    Research

    Routine Axillary Ultrasound for Patients with T1-T2 Breast Cancer Does Not Increase the Rate of Axillary Lymph Node Dissection Based on Predictive Modeling

    2018

    Via Annals of Surgical Oncology

    Research

    ASBRS Great Debate: Sentinel Node Biopsy in Patients Over 70 Years of Age

    2018

    Via Annals of Surgical Oncology

    Research

    Treatment delays from transfers of care and their impact on breast cancer quality measures

    2018

    Via Breast Cancer Research and Treatment